Pranay S. Ajay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pranay S. Ajay has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Mihir M. Shah
MedStar Washington Hospital Center
10 shared publications - David A. Kooby
Department of Surgery Emory University School of Medicine Atlanta Georgia USA
7 shared publications Subir Goyal
Biostatistics Shared Resource, Winship Cancer Institute Emory University Atlanta Georgia USA
5 shared publicationsCaitlin P. Sok
Division of Surgical Oncology, Department of Surgery Emory University School of Medicine Atlanta Georgia USA
3 shared publicationsJeffery M. Switchenko
Biostatistics Shared Resource, Winship Cancer Institute Emory University Atlanta Georgia USA
3 shared publications- Kenneth Cardona
Department of Surgery Emory University School of Medicine Atlanta Georgia USA
3 shared publications
Latest Publications
- 18 June 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (2) , 308-316
Decreasing Complications After Ivor‐Lewis Esophagectomy: Is a Totally Minimally Invasive Approach the Solution?
Background: Despite improvements over time, Ivor Lewis Esophagectomy (ILE), a potentially curative surgical option for patients with invasive esophageal cancer, carries high morbidity and mortality. We analyzed postoperative outcomes in patients undergoing ILE at our institution, comparing open (OE), hybrid (HE), and totally minimally invasive (TMIE) approaches.Methods: We reviewed the records of patients who underwent elective ILE for benign or malignant pathology at our institution (2018–2022). Patients who underwent transhiatal or McKeown esophagectomy, as well as those undergoing emergent procedures, were excluded. Factors associated with major postoperative complications (Clavien‐Dindo Grade ≥ 3) were assessed using multivariable analysis (MVA).Results: Of 260 patients, 135 met the inclusion criteria: 40 (29.6%) underwent OE, 50 (37.0%) underwent HE, and 45 (33.3%) underwent TMIE. Median length of stay was shorter for patients undergoing TMIE compared to OE and HE (9 vs. 12 and 13 days, p < 0.001). A higher major postoperative complication rate was noted in patients undergoing OE and HE compared to TMIE (32.5% and 36% vs. 13.3%) (p = 0.03). This result persisted on MVA (OE: aOR 3.4, p = 0.04; HE: aOR 5.5, p = 0.002; reference:TMIE).Conclusion: A totally minimally invasive approach to Ivor‐Lewis Esophagectomy is associated with lower major postoperative complications and shortened length of stay at our institution. Prospective evaluations in the United States population are warranted to optimize and standardize surgical approaches.
- 18 June 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (2) , 308-316
Decreasing Complications After Ivor‐Lewis Esophagectomy: Is a Totally Minimally Invasive Approach the Solution?
Background: Despite improvements over time, Ivor Lewis Esophagectomy (ILE), a potentially curative surgical option for patients with invasive esophageal cancer, carries high morbidity and mortality. We analyzed postoperative outcomes in patients undergoing ILE at our institution, comparing open (OE), hybrid (HE), and totally minimally invasive (TMIE) approaches.Methods: We reviewed the records of patients who underwent elective ILE for benign or malignant pathology at our institution (2018–2022). Patients who underwent transhiatal or McKeown esophagectomy, as well as those undergoing emergent procedures, were excluded. Factors associated with major postoperative complications (Clavien‐Dindo Grade ≥ 3) were assessed using multivariable analysis (MVA).Results: Of 260 patients, 135 met the inclusion criteria: 40 (29.6%) underwent OE, 50 (37.0%) underwent HE, and 45 (33.3%) underwent TMIE. Median length of stay was shorter for patients undergoing TMIE compared to OE and HE (9 vs. 12 and 13 days, p < 0.001). A higher major postoperative complication rate was noted in patients undergoing OE and HE compared to TMIE (32.5% and 36% vs. 13.3%) (p = 0.03). This result persisted on MVA (OE: aOR 3.4, p = 0.04; HE: aOR 5.5, p = 0.002; reference:TMIE).Conclusion: A totally minimally invasive approach to Ivor‐Lewis Esophagectomy is associated with lower major postoperative complications and shortened length of stay at our institution. Prospective evaluations in the United States population are warranted to optimize and standardize surgical approaches.
- 8 January 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (7) , 1343-1351
Reducing Postoperative Opioid Use: A Comparison of Open Versus Ultrasound‐Guided Regional Anesthesia for Patients Undergoing Open Pancreatoduodenectomy
Background: Opioid crisis is a national issue with significant economic burden and marked increase in opioid‐related deaths, particularly following surgical procedures. Reducing opioid requirements while maintaining effective analgesia is critically challenging, perioperatively. Multimodal drug regimens and guided regional anesthesia (RA) have been adopted to address this issue. We aimed to assess postoperative opioid consumption in patients undergoing open pancreatoduodenectomy based on the routes of RA administration: open versus ultra‐sound guided.Methods: This retrospective cohort study was conducted at Emory University Saint Joseph's Hospital, encompassing patients who underwent open pancreatoduodenectomy (PD) from 2020 to 2022 who received ultrasound‐guided RA (U‐RA) or open RA (O‐RA). Patient demographics, surgical details, and postoperative outcomes, including opioid consumption measured in morphine milligram equivalents (MME) at 24, 48, and 72 h, were analyzed. Multivariable linear regression identified predictors of postoperative opioid use.Results: Of 95 patients, 47 met inclusion criteria: 27 received U‐RA and 20 O‐RA. Preoperative and intraoperative characteristics were similar between patients receiving O‐RA and U‐RA. A lower opioid requirement was noted in the O‐RA group compared to the U‐RA group at all time points. (24 h: 6.5 vs. 18, p = 0.004; 48 h: 18 vs. 37, p = 0.001; 72 h: 30.5 vs. 57, p = 0.002). On multivariable analysis, only route of regional anesthesia was independently associated with reduced opioid use across all time points (24 h: mean difference = −5.75, 95% CI: −11.3, −0.18; 48 h: mean difference = −16.95, 95% CI: −27.5, −6.4; 72 h: mean difference = −20.39, 95% CI: −35.4, −5.3) Patient age, gender, race, obesity, neoadjuvant chemotherapy, small pancreatic duct, and pancreatic fistula were not independently associated with opioid use.Conclusions: O‐RA may offer a better approach than U‐RA in minimizing opioid consumption after open PD. These findings suggest the incorporation of O‐RA for upper abdominal surgeries to decrease the necessity of postoperative opioids.
- 8 January 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (7) , 1343-1351
Reducing Postoperative Opioid Use: A Comparison of Open Versus Ultrasound‐Guided Regional Anesthesia for Patients Undergoing Open Pancreatoduodenectomy
Background: Opioid crisis is a national issue with significant economic burden and marked increase in opioid‐related deaths, particularly following surgical procedures. Reducing opioid requirements while maintaining effective analgesia is critically challenging, perioperatively. Multimodal drug regimens and guided regional anesthesia (RA) have been adopted to address this issue. We aimed to assess postoperative opioid consumption in patients undergoing open pancreatoduodenectomy based on the routes of RA administration: open versus ultra‐sound guided.Methods: This retrospective cohort study was conducted at Emory University Saint Joseph's Hospital, encompassing patients who underwent open pancreatoduodenectomy (PD) from 2020 to 2022 who received ultrasound‐guided RA (U‐RA) or open RA (O‐RA). Patient demographics, surgical details, and postoperative outcomes, including opioid consumption measured in morphine milligram equivalents (MME) at 24, 48, and 72 h, were analyzed. Multivariable linear regression identified predictors of postoperative opioid use.Results: Of 95 patients, 47 met inclusion criteria: 27 received U‐RA and 20 O‐RA. Preoperative and intraoperative characteristics were similar between patients receiving O‐RA and U‐RA. A lower opioid requirement was noted in the O‐RA group compared to the U‐RA group at all time points. (24 h: 6.5 vs. 18, p = 0.004; 48 h: 18 vs. 37, p = 0.001; 72 h: 30.5 vs. 57, p = 0.002). On multivariable analysis, only route of regional anesthesia was independently associated with reduced opioid use across all time points (24 h: mean difference = −5.75, 95% CI: −11.3, −0.18; 48 h: mean difference = −16.95, 95% CI: −27.5, −6.4; 72 h: mean difference = −20.39, 95% CI: −35.4, −5.3) Patient age, gender, race, obesity, neoadjuvant chemotherapy, small pancreatic duct, and pancreatic fistula were not independently associated with opioid use.Conclusions: O‐RA may offer a better approach than U‐RA in minimizing opioid consumption after open PD. These findings suggest the incorporation of O‐RA for upper abdominal surgeries to decrease the necessity of postoperative opioids.
- 7 September 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8756-8757
ASO Author Reflections: Prioritizing Pfannenstiel Incision for Reduced Hernia Risk in Minimally Invasive Distal Pancreatectomy
- 7 September 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8756-8757
ASO Author Reflections: Prioritizing Pfannenstiel Incision for Reduced Hernia Risk in Minimally Invasive Distal Pancreatectomy
- 27 August 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 130 (5) , 1078-1091
Comparison of treatment strategies based on clinical and pathological nodal status in resectable gastric adenocarcinoma
Background: To determine the optimal multimodal treatment strategy between perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), and postoperative chemotherapy (POC) in resected gastric cancer (GC) patients based on nodal status. Methods: In this retrospective analysis, the National Cancer Database was used to identify resected non‐metastatic GC (2006−2016). Patients were stratified by clinical nodal status—negative (cLN−) and positive (cLN+). In patients with cLN− disease who underwent upfront resection and were upstaged to pathological LN+, overall survival (OS) was compared between POC and POCR. In patients with cLN− and cLN+ disease, OS was compared between PEC, POCR, and POC. Kaplan−Meier survival estimate, log‐rank test, and multivariable Cox proportional hazards analysis were performed. Results: We identified 7827 patients (cLN− 4828; cLN+ 2999). On multivariable analysis in patients with cLN− disease who underwent upfront resection ( n = 4314) and were upstaged to pLN+ disease (70%), POCR ( n = 2300, aHR 0.78, 95% CI 0.70−0.87, p < 0.001) was associated with improved OS compared to POC ( n = 907). No significant difference was noted between POCR ( n = 766, aHR 1.11, 95% CI 0.88−1.40, p = 0.39) and POC ( n = 341) in patients with pLN− disease. On multivariable analysis in all patients with cLN− disease, POCR ( n = 3066) was significantly associated with improved OS (aHR 0.84, 95% CI 0.75−0.92, p < 0.01) compared to POC ( n = 1248). No significant difference was noted between POCR (aHR 1.0, 95% CI 0.70−1.01, p = 0.958) and PEC ( n = 514). These results remained consistent in patients with cLN+ disease (POCR = 1602, POC = 720, PEC = 677). Conclusion: Postoperative chemoradiation is associated with improved survival in GC patients upstaged from clinically node‐negative disease to pathologically node‐positive disease. Negative clinical nodal disease status is not a reliable indicator of pathological nodal disease.
- 27 August 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 130 (5) , 1078-1091
Comparison of treatment strategies based on clinical and pathological nodal status in resectable gastric adenocarcinoma
Background: To determine the optimal multimodal treatment strategy between perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), and postoperative chemotherapy (POC) in resected gastric cancer (GC) patients based on nodal status. Methods: In this retrospective analysis, the National Cancer Database was used to identify resected non‐metastatic GC (2006−2016). Patients were stratified by clinical nodal status—negative (cLN−) and positive (cLN+). In patients with cLN− disease who underwent upfront resection and were upstaged to pathological LN+, overall survival (OS) was compared between POC and POCR. In patients with cLN− and cLN+ disease, OS was compared between PEC, POCR, and POC. Kaplan−Meier survival estimate, log‐rank test, and multivariable Cox proportional hazards analysis were performed. Results: We identified 7827 patients (cLN− 4828; cLN+ 2999). On multivariable analysis in patients with cLN− disease who underwent upfront resection ( n = 4314) and were upstaged to pLN+ disease (70%), POCR ( n = 2300, aHR 0.78, 95% CI 0.70−0.87, p < 0.001) was associated with improved OS compared to POC ( n = 907). No significant difference was noted between POCR ( n = 766, aHR 1.11, 95% CI 0.88−1.40, p = 0.39) and POC ( n = 341) in patients with pLN− disease. On multivariable analysis in all patients with cLN− disease, POCR ( n = 3066) was significantly associated with improved OS (aHR 0.84, 95% CI 0.75−0.92, p < 0.01) compared to POC ( n = 1248). No significant difference was noted between POCR (aHR 1.0, 95% CI 0.70−1.01, p = 0.958) and PEC ( n = 514). These results remained consistent in patients with cLN+ disease (POCR = 1602, POC = 720, PEC = 677). Conclusion: Postoperative chemoradiation is associated with improved survival in GC patients upstaged from clinically node‐negative disease to pathologically node‐positive disease. Negative clinical nodal disease status is not a reliable indicator of pathological nodal disease.
- 17 October 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (8) , 1461-1463
Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer
- 17 October 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (8) , 1461-1463
Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer
- 28 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (2) , 242-253
Impact of nodal status in determining multimodal treatment strategies in non‐cardia gastric cancer
Background: Patients with resectable noncardia gastric cancer may be subjected to perioperative chemotherapy (PEC), postoperative chemoradiation (POCR), or postoperative chemotherapy (POC). We analyzed these treatment strategies to determine optimal therapy based on nodal status.Method: The National Cancer Database was used to identify patients with resected noncardia gastric cancer (2004–2016). Patients were stratified based on clinical nodal status–negative (cLN−), positive (cLN+) and pathological nodal status (pLN−, pLN+). In cLN− patients who underwent upfront resection and were upstaged to pLN+, POC, and POCR were compared. Overall survival (OS) with PEC, POCR, and POC were compared in cLN− and cLN+.Results: We identified 6142 patients (cLN−: 3831; cLN+: 2311). In cLN− patients who underwent upfront resection (N = 3423), 69% were upstaged to pLN+ disease (N = 2499; POCR = 1796, POC = 703). On MVA, POCR was associated with significantly improved OS when compared to POC (hazard ratio [HR]: 0.75; p < 0.001).In patients with cLN− disease (PEC = 408; POCR = 2439; POC = 984), PEC(HR: 0.77; p = 0.01) and POCR(HR: 0.81; p < 0.001) were associated with improved OS compared with POC. In cLN+ group (PEC = 452; POCR = 1284; POC = 575), POCR was associated with improved OS compared with POC (HR: 0.81; p < 0.01), and trend towards improved OS was noted when PEC(HR: 0.83; p = 0.055) was compared with POC.Conclusion: Postoperative chemoradiation may be the preferred treatment strategy over postoperative chemotherapy in non‐cardia gastric cancer patients who receive upfront resection and are upstaged from clinically node negative to pathologically node positive disease.
- 28 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (2) , 242-253
Impact of nodal status in determining multimodal treatment strategies in non‐cardia gastric cancer
Background: Patients with resectable noncardia gastric cancer may be subjected to perioperative chemotherapy (PEC), postoperative chemoradiation (POCR), or postoperative chemotherapy (POC). We analyzed these treatment strategies to determine optimal therapy based on nodal status.Method: The National Cancer Database was used to identify patients with resected noncardia gastric cancer (2004–2016). Patients were stratified based on clinical nodal status–negative (cLN−), positive (cLN+) and pathological nodal status (pLN−, pLN+). In cLN− patients who underwent upfront resection and were upstaged to pLN+, POC, and POCR were compared. Overall survival (OS) with PEC, POCR, and POC were compared in cLN− and cLN+.Results: We identified 6142 patients (cLN−: 3831; cLN+: 2311). In cLN− patients who underwent upfront resection (N = 3423), 69% were upstaged to pLN+ disease (N = 2499; POCR = 1796, POC = 703). On MVA, POCR was associated with significantly improved OS when compared to POC (hazard ratio [HR]: 0.75; p < 0.001).In patients with cLN− disease (PEC = 408; POCR = 2439; POC = 984), PEC(HR: 0.77; p = 0.01) and POCR(HR: 0.81; p < 0.001) were associated with improved OS compared with POC. In cLN+ group (PEC = 452; POCR = 1284; POC = 575), POCR was associated with improved OS compared with POC (HR: 0.81; p < 0.01), and trend towards improved OS was noted when PEC(HR: 0.83; p = 0.055) was compared with POC.Conclusion: Postoperative chemoradiation may be the preferred treatment strategy over postoperative chemotherapy in non‐cardia gastric cancer patients who receive upfront resection and are upstaged from clinically node negative to pathologically node positive disease.
- 10 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (2) , 231-241
Does non‐metastatic gastric cancer of the cardia warrant a different treatment strategy?
Background: Multimodal treatment strategies with surgery as its centerpiece have been accepted as the standard of care in nonmetastatic cardia gastric cancer (CGC). There remains a lack of consensus regarding the optimal multimodal treatment strategy.Method: We queried National Cancer Database from 2004 to 2016 to identify patients with resected nonmetastatic CGC who received perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), or postoperative chemotherapy (POC). A subgroup analysis was performed in optimally treated patients defined as initial chemotherapy within 45 days of diagnosis, resection within 45 days of diagnosis, negative margins, adjuvant chemotherapy within 90 days of resection, and standard radiation dose (45 Gy). Kaplan–Meier, Univariate analysis (UVA), and Multivariable analysis (MVA) were performed.Results: We identified 2387 patients. Median survival was 38.8 months in the PEC group, 36 months in the POCR group, and 32.3 months in the POC group (p = 0.1025). On UVA, patients treated with PEC had an association with improved survival (HR, 0.83; p = 0.037) when compared with POC. On MVA, no significant difference was noted in overall survival (OS) between PEC, POCR, and POC, similar to subgroup analysis of optimally treated cohort.Conclusion: OS rate in nonmetastatic CGC is not significantly different between patients receiving PEC, POCR, or POC.
- 10 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (2) , 231-241
Does non‐metastatic gastric cancer of the cardia warrant a different treatment strategy?
Background: Multimodal treatment strategies with surgery as its centerpiece have been accepted as the standard of care in nonmetastatic cardia gastric cancer (CGC). There remains a lack of consensus regarding the optimal multimodal treatment strategy.Method: We queried National Cancer Database from 2004 to 2016 to identify patients with resected nonmetastatic CGC who received perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), or postoperative chemotherapy (POC). A subgroup analysis was performed in optimally treated patients defined as initial chemotherapy within 45 days of diagnosis, resection within 45 days of diagnosis, negative margins, adjuvant chemotherapy within 90 days of resection, and standard radiation dose (45 Gy). Kaplan–Meier, Univariate analysis (UVA), and Multivariable analysis (MVA) were performed.Results: We identified 2387 patients. Median survival was 38.8 months in the PEC group, 36 months in the POCR group, and 32.3 months in the POC group (p = 0.1025). On UVA, patients treated with PEC had an association with improved survival (HR, 0.83; p = 0.037) when compared with POC. On MVA, no significant difference was noted in overall survival (OS) between PEC, POCR, and POC, similar to subgroup analysis of optimally treated cohort.Conclusion: OS rate in nonmetastatic CGC is not significantly different between patients receiving PEC, POCR, or POC.
- 5 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (1) , 51-57
Early experience with robotic central pancreatectomy with patient‐reported outcomes and comparison with open central pancreatectomy
Background: Robotic central pancreatectomy (CP) has emerged in recent years as a noninferior approach to open CP and may offer improved patient‐reported outcomes and reduction in incisional hernias.Methods: All patients who underwent open and robotic CP between (2013 and 2022) were selected, and perioperative outcomes were analyzed. Patients who underwent robotic CP were interviewed over the phone to assess patient‐reported postoperative outcomes.Results: A total of 18 CP operations (56%—open vs. 44%—robotic) were identified. The overall median age was 67 years (interquartile range: 60–72), and 50% (n = 9) of patients were female. Median length of surgery was statistically longer for robotic CP (411 vs. 138 min, p = 0.002); all other intraoperative variables were similar. Postoperatively, a similar number of patients in the open and robotic cohorts developed clinically significant postoperative pancreatic fistulas (37.5% vs. 30%, p = 1) and major complications (37.5% vs. 20%, p = 0.60), respectively. No patients in the robotic cohort developed an incisional hernia, compared to 40% (n = 4) in open (p = 0.08). All patients returned to a baseline level of activity and reported a high quality of life.Conclusion: With the exception of longer operative times, robotic CP is a noninferior, definitive resection technique for select lesions of the middle pancreas. Additionally, the robotic approach may result in a reduction in incisional hernia development.
- 5 April 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (1) , 51-57
Early experience with robotic central pancreatectomy with patient‐reported outcomes and comparison with open central pancreatectomy
Background: Robotic central pancreatectomy (CP) has emerged in recent years as a noninferior approach to open CP and may offer improved patient‐reported outcomes and reduction in incisional hernias.Methods: All patients who underwent open and robotic CP between (2013 and 2022) were selected, and perioperative outcomes were analyzed. Patients who underwent robotic CP were interviewed over the phone to assess patient‐reported postoperative outcomes.Results: A total of 18 CP operations (56%—open vs. 44%—robotic) were identified. The overall median age was 67 years (interquartile range: 60–72), and 50% (n = 9) of patients were female. Median length of surgery was statistically longer for robotic CP (411 vs. 138 min, p = 0.002); all other intraoperative variables were similar. Postoperatively, a similar number of patients in the open and robotic cohorts developed clinically significant postoperative pancreatic fistulas (37.5% vs. 30%, p = 1) and major complications (37.5% vs. 20%, p = 0.60), respectively. No patients in the robotic cohort developed an incisional hernia, compared to 40% (n = 4) in open (p = 0.08). All patients returned to a baseline level of activity and reported a high quality of life.Conclusion: With the exception of longer operative times, robotic CP is a noninferior, definitive resection technique for select lesions of the middle pancreas. Additionally, the robotic approach may result in a reduction in incisional hernia development.
- 27 August 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (12) , 2570-2571
Reply to: Radical treatment for stage IV gallbladder cancers: Is surgery a worthwhile exercise in advanced cancers?
- 27 August 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (12) , 2570-2571
Reply to: Radical treatment for stage IV gallbladder cancers: Is surgery a worthwhile exercise in advanced cancers?
- 17 August 2022
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (8) , 1423-1429
A review of hepatic epithelioid hemangioendothelioma—Analyzing patient characteristics and treatment strategies
Background: Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of unknown etiology and unpredictable natural history. To date, no large‐scale studies have been published evaluating this disease due to its rare occurrence. Methods: The National Cancer Database was reviewed between 2004 and 2016 to identify patients with HEH. Univariate analysis with overall survival (OS) was performed by Cox proportional hazards model. Kaplan–Meier method was used to create OS curves and compared using the log‐rank test. Results: We identified 229 patients with HEH. The majority of patients were female (61.1%), white (84.3%), and had a Charlson–Deyo score of 0 (75%). Chemotherapeutic intervention was seen in 26% of the patients while 33% received surgical intervention in the form of wedge/segmental liver resection ( n = 27), hepatectomy lobectomy/extended lobectomy ( n = 18), and liver transplant ( n = 22). Five‐year survival in surgical patients was 90.5%, 66.5% and 81%, respectively ( p = 0.485). Age greater than 55 years (hazard ratio [HR], 2.78; p < 0.001), Asian ethnicity compared to white (HR, 2.84; p = 0.012), and a higher Charlson–Deyo score (score 1: HR, 2.28; p < 0.001 and score ≥2: HR, 2.76; p = 0.011) were associated with worse OS. Conclusion: Treatment for HEH remains variable with only a third of the patients undergoing surgery. International collaboration is necessary to determine the optimal treatment for this rare disease.
- 17 August 2022
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (8) , 1423-1429
A review of hepatic epithelioid hemangioendothelioma—Analyzing patient characteristics and treatment strategies
Background: Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of unknown etiology and unpredictable natural history. To date, no large‐scale studies have been published evaluating this disease due to its rare occurrence. Methods: The National Cancer Database was reviewed between 2004 and 2016 to identify patients with HEH. Univariate analysis with overall survival (OS) was performed by Cox proportional hazards model. Kaplan–Meier method was used to create OS curves and compared using the log‐rank test. Results: We identified 229 patients with HEH. The majority of patients were female (61.1%), white (84.3%), and had a Charlson–Deyo score of 0 (75%). Chemotherapeutic intervention was seen in 26% of the patients while 33% received surgical intervention in the form of wedge/segmental liver resection ( n = 27), hepatectomy lobectomy/extended lobectomy ( n = 18), and liver transplant ( n = 22). Five‐year survival in surgical patients was 90.5%, 66.5% and 81%, respectively ( p = 0.485). Age greater than 55 years (hazard ratio [HR], 2.78; p < 0.001), Asian ethnicity compared to white (HR, 2.84; p = 0.012), and a higher Charlson–Deyo score (score 1: HR, 2.28; p < 0.001 and score ≥2: HR, 2.76; p = 0.011) were associated with worse OS. Conclusion: Treatment for HEH remains variable with only a third of the patients undergoing surgery. International collaboration is necessary to determine the optimal treatment for this rare disease.